ERBB2 and breast cancer: SBS8 (unknown etiology; C > A/T > A dominance) was elevated in PM from ILC HR + HER2- breast cancer, ANSC, GINET, THPA, CCOV, LNET, and PLMESO (Fig. 6b, c).